Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (Adderall XR) for Cognitive Impairment in MS

NCT02676739 is registered in ClinicalTrials.gov with Sarah Morrow as lead sponsor.

NCT NCT02676739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02676739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (Adderall XR) for Cognitive Impairment in MS
Lead sponsor
Sarah Morrow
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
May 20, 2016
Completion date
December 31, 2024
Enrollment
180 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis